These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33533494)

  • 21. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
    Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
    Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
    Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Pathological Characteristics of
    Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
    Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
    [No Abstract]   [Full Text] [Related]  

  • 26. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.
    Kim Y; Hammerman PS; Kim J; Yoon JA; Lee Y; Sun JM; Wilkerson MD; Pedamallu CS; Cibulskis K; Yoo YK; Lawrence MS; Stojanov P; Carter SL; McKenna A; Stewart C; Sivachenko AY; Oh IJ; Kim HK; Choi YS; Kim K; Shim YM; Kim KS; Song SY; Na KJ; Choi YL; Hayes DN; Kim J; Cho S; Kim YC; Ahn JS; Ahn MJ; Getz G; Meyerson M; Park K
    J Clin Oncol; 2014 Jan; 32(2):121-8. PubMed ID: 24323028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.
    Schwaederle M; Elkin SK; Tomson BN; Carter JL; Kurzrock R
    Cell Cycle; 2015; 14(14):2355-61. PubMed ID: 26030731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SETD2 histone modifier loss in aggressive GI stromal tumours.
    Huang KK; McPherson JR; Tay ST; Das K; Tan IB; Ng CC; Chia NY; Zhang SL; Myint SS; Hu L; Rajasegaran V; Huang D; Loh JL; Gan A; Sairi AN; Sam XX; Dominguez LT; Lee M; Soo KC; Ooi LL; Ong HS; Chung A; Chow PK; Wong WK; Selvarajan S; Ong CK; Lim KH; Nandi T; Rozen S; Teh BT; Quek R; Tan P
    Gut; 2016 Dec; 65(12):1960-1972. PubMed ID: 26338826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients.
    Kim HC; Lee S; Song JW
    Sci Rep; 2021 Apr; 11(1):8312. PubMed ID: 33859288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family.
    Zheng CM; Zhan X; Yang YH; Jiang T; Ye Q; Lu Y
    Chin Med J (Engl); 2018 Sep; 131(18):2205-2209. PubMed ID: 30203795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.
    Gambichler T; Rüddel I; Hessam S; Bechara FG; Stockfleth E; Schmitz L
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1485-1491. PubMed ID: 29478287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
    Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
    Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
    Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
    Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Yoo H; Jeong BH; Chung MJ; Lee KS; Kwon OJ; Chung MP
    BMC Pulm Med; 2019 Aug; 19(1):149. PubMed ID: 31412851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
    Tzouvelekis A; Karampitsakos T; Gomatou G; Bouros E; Tzilas V; Manali E; Tomos I; Trachalaki A; Kolilekas L; Korbila I; Tomos P; Chrysikos S; Gaga M; Daniil Z; Bardaka F; Papanikolaou IC; Euthymiou C; Papakosta D; Steiropoulos P; Ntolios P; Tringidou R; Papiris S; Antoniou K; Bouros D
    Pulm Pharmacol Ther; 2020 Feb; 60():101880. PubMed ID: 31874284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.